AAA

NFL BIOSCIENCES S.A.

No trades
See on Supercharts
Market capitalization
‪19.80 M‬EUR
−0.480EUR
‪−3.75 M‬EUR
Beta (1Y)
2.57

About NFL BIOSCIENCES S.A.

CEO
Ignacio Faus
Headquarters
Castelnau-le-Lez
Employees (FY)
3
Founded
2006
ISIN
FR0014003XT0
FIGI
BBG011FP2ZX8
NFL Biosciences SAS is a biotechnology company, which engages in the development of botanical drug candidates for the treatment of tobacco addiction and neurological diseases. Its pipeline includes NFL-101 tobacco extract; NFL-201 cannabis and tobacco extract; and NFL-301 botanical extract. The company was founded by Bruno Lafont and Jean-Pierre Nicolas in September 2006 and is headquartered in Castelnau-le-Lez, France.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ALNFL is 1.970 EUR — it has decreased by 4.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on EURONEXT exchange NFL BIOSCIENCES S.A. stocks are traded under the ticker ALNFL.
ALNFL stock is 6.09% volatile and has beta coefficient of 2.57. Check out the list of the most volatile stocks — is NFL BIOSCIENCES S.A. there?
Yes, you can track NFL BIOSCIENCES S.A. financials in yearly and quarterly reports right on TradingView.
ALNFL stock has fallen by 0.10% compared to the previous week, the month change is a 26.22% fall, over the last year NFL BIOSCIENCES S.A. has showed a 27.84% decrease.
ALNFL net income for the last quarter is ‪−1.63 M‬ EUR, while the quarter before that showed ‪−2.11 M‬ EUR of net income which accounts for 22.54% change. Track more NFL BIOSCIENCES S.A. financial stats to get the full picture.
No, ALNFL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ALNFL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NFL BIOSCIENCES S.A. stock right from TradingView charts — choose your broker and connect to your account.
ALNFL reached its all-time high on Oct 8, 2021 with the price of 5.000 EUR, and its all-time low was 0.550 EUR and was reached on May 24, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 26, 2024, the company has 3.00 employees. See our rating of the largest employees — is NFL BIOSCIENCES S.A. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NFL BIOSCIENCES S.A. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NFL BIOSCIENCES S.A. stock shows the strong sell signal. See more of NFL BIOSCIENCES S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on NFL BIOSCIENCES S.A. future price: according to them, ALNFL price has a max estimate of 5.70 EUR and a min estimate of 4.20 EUR. Read a more detailed NFL BIOSCIENCES S.A. forecast: see what analysts think of NFL BIOSCIENCES S.A. and suggest that you do with its stocks.